Evidence map›Paper›PMID 28919711›Full record

ArticleDrug design, development and therapy2017

Protective role of quercetin against manganese-induced injury in the liver, kidney, and lung; and hematological parameters in acute and subchronic rat models.

Entaz Bahar, Geum-Hwa Lee, Kashi Raj Bhattarai, Hwa-Young Lee, Hyun-Kyoung Kim, Mallikarjun Handigund, Min-Kyung Choi, Sun-Young Han, Han-Jung Chae, Hyonok Yoon

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Drug design, development and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Effect of quercetin on oxidative stress and liver function in beta-thalassemia major patients receiving desferrioxamine: A double-blind randomized clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Entaz BaharCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju.
Geum-Hwa LeeDepartment of Pharmacology, Medical School, Chonbuk National University.
Kashi Raj BhattaraiDepartment of Pharmacology, Medical School, Chonbuk National University.
Hwa-Young LeeDepartment of Pharmacology, Medical School, Chonbuk National University.
Hyun-Kyoung KimDepartment of Pharmacology, Medical School, Chonbuk National University.
Mallikarjun HandigundDepartment of Laboratory Medicine, Chonbuk National University Hospital, Jeonju, Republic of Korea.
Min-Kyung ChoiDepartment of Pharmacology, Medical School, Chonbuk National University.
Sun-Young HanCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju.
Han-Jung ChaeDepartment of Pharmacology, Medical School, Chonbuk National University.
Hyonok YoonCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju.
Jeonbuk National University · KRGyeongsang National University · KRJeonbuk National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Manganese (Mn) is an important mineral element required in trace amounts for development of the human body, while over- or chronic-exposure can cause serious organ toxicity. The current study was designed to evaluate the protective role of quercetin (Qct) against Mn-induced toxicity in the liver, kidney, lung, and hematological parameters in acute and subchronic rat models. Male Sprague Dawley rats were divided into control, Mn (100 mg/kg for acute model and 15 mg/kg for subchronic model), and Mn + Qct (25 and 50 mg/kg) groups in both acute and subchronic models. Our result revealed that Mn + Qct groups effectively reduced Mn-induced ALT, AST, and creatinine levels. However, Mn + Qct groups had effectively reversed Mn-induced alteration of complete blood count, including red blood cells, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets, and white blood cells. Meanwhile, the Mn + Qct groups had significantly decreased neutrophil and eosinophil and increased lymphocyte levels relative to the Mn group. Additionally, Mn + Qct groups showed a beneficial effect against Mn-induced macrophages and neutrophils. Our result demonstrated that Mn + Qct groups exhibited protective effects on Mn-induced alteration of GRP78, CHOP, and caspase-3 activities. Furthermore, histopathological observation showed that Mn + Qct groups effectively counteracted Mn-induced morphological change in the liver, kidney, and lung. Moreover, immunohistochemically Mn + Qct groups had significantly attenuated Mn-induced 8-oxo-2'-deoxyguanosine immunoreactivity. Our study suggests that Qct could be a substantially promising organ-protective agent against toxic Mn effects and perhaps against other toxic metal chemicals or drugs.

Indexed as

AnimalsAntioxidantsDisease Models, AnimalEndoplasmic Reticulum Chaperone BiPKidneyLiverLungMacrophagesMaleManganeseNeutrophilsProtective AgentsQuercetinRatsRats, Sprague-DawleyAntioxidantsEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanManganeseProtective AgentsQuercetinhematological parameterskidneyliverlungmanganesequercetin

Identifiers

PMID28919711
PMCPMC5592961
OpenAlexW2752562225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.